Concepedia

Martin Degen

MD

Statistics

Publications

22

Citations

1.1K

H-Index

17

Active since

2002

Affiliations

Novartis (Switzerland)(Current)

Friedrich Miescher Institute

University of Bern

University of Basel

University Hospital of Basel

Martin Degen is an author at Novartis (Switzerland) specializing in medicine, oncology, and molecular biology.

Publications per year

2002–2021

22

Publications

22

Role of cytoplasmic C-terminal amino acids of membrane proteins in ER export

Oliver Nufer, Svend Guldbrandsen, Martin Degen et al. · Journal of Cell Science · 2002 · 155 citations

Life Sciences, Biochemistry, Molecular Biology +16

Tenascin-C Is a Novel RBPJκ-Induced Target Gene for Notch Signaling in Gliomas

Balasubramanian Sivasankaran, Martin Degen, Anthony Ghaffari et al. · Cancer Research · 2009 · 133 citations

Medicine, Molecular Biology, Oncology +17

Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro

Arnaud Scherberich, Richard P. Tucker, Martin Degen et al. · Oncogene · 2004 · 98 citations

Veterinary Medicine, Cancer Biology, Cell Biology +12

Clinical Classification of Cancer Cachexia: Phenotypic Correlates in Human Skeletal Muscle

Neil Johns, Shinji Hatakeyama, Nathan Stephens et al. · PLoS ONE · 2014 · 90 citations · Full text

Medicine, Oncology, Pathology +17

Tenascin-W Is a Novel Marker for Activated Tumor Stroma in Low-grade Human Breast Cancer and Influences Cell Behavior

Martin Degen, Florence Brellier, Renate Kain et al. · Cancer Research · 2007 · 73 citations

Medicine, Cancer Biology, Oncology +13

1–5 of 22